Alvotech and Dr. Reddy’s enter into collaboration for its biosimilar to treat osteoporosis
Alvotech and Dr. Reddy’s Laboratories have unveiled a new license and supply agreement on Tuesday, targeting the commercialization of AVT03, Alvotech’s biosimilar counterpart to Prolia and Xgeva (denosumab). According to…